                </a></li></ul></div><p><strong>Figure 4. </strong></p><a id="article1.body1.sec2.sec3.fig1.caption1.p1" name="article1.body1.sec2.sec3.fig1.caption1.p1"></a><p>The inhibitory effect of PPARα resides in the hematopoietic compartment. (A) B16-BL6 melanoma growth in WT mice receiving KO bone marrow (KO BM →WT mice) compared to PPARα KO mice receiving WT bone marrow (WT BM →KO mice). WT bone marrow “rescues” tumor growth in PPARα KO mice. (B) Subcutaneous B16-BL6 tumors on day 28 post-implantation show abundant CD45 staining in PPARα WT mice receiving KO bone marrow (KO →WT). In B16-BL6 tumors in KO mice receiving WT bone marrow (WT→KO) CD45 staining (shown in green) was markedly reduced. Hoechst staining of nuclei is blue. Scale bar, 100 µM. (C) Effect of granulocyte depletion using Gr-1 antibody or control antibody (Ctr Ab, IgG2b) on B16-BL6 melanoma growth rate in PPARα KO and WT mice.</p>
<span>THISISTHEEND
